Merck Serono and Fast Forward, LLC Announce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis




Pressemitteilung



Merck Serono SA

Pressetitel

Merck Serono and Fast Forward, LLC Announce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis

Verfasser / Quelle

Merck Serano

Publikationsdatum

18.03.2009



- - - - - - - - - - START HELP.CH - PRESSEMITTEILUNG - - - - - - - - - -

18.03.2009, Geneva, Switzerland. Merck Serono, a division of Merck KGaA, Darmstadt Germany, and Fast Forward, LLC, a wholly-owned subsidiary of the American National Multiple Sclerosis Society, today announced a collaborative partnership to evaluate and fund promising multiple sclerosis (MS) research projects. Proposals will be jointly developed by Merck Serono and Fast Forward. Merck KGaA will provide up to $19 million in funding. The funds will support early stage clinical development projects with biotech companies or projects with individual researchers or academic institutions.


“Merck Serono and the American National Multiple Sclerosis Society have an unwavering commitment to the support of early stage research in the quest to find new and improved treatment options for MS patients.

It is with great excitement that our organization supports this initiative with Fast Forward, which will explore new avenues to advance new MS treatments with the potential to transform people’s lives,” said Fereydoun Firouz, President and CEO of EMD Serono Inc. in the USA.



Über Merck Serono SA

Merck Serono is a unique Biotech company, with a global presence and fully integrated from discovery to market. We are a world leader in the field of biotechnology. We compete for leadership in all the markets in which we operate. Our competitive advantage is derived from achieving superior performance above and beyond the sum of our parts.

In achieving our goals we maximise the return on investment of our shareholders. Our overall aim is to develop innovative products to address unmet medical needs and improve the quality of life of our patients.


Quelle:
HELP.ch


- ENDE HELP.CH - PRESSEMITTEILUNG Merck Serono and Fast Forward, LLC Announce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis -

Quelle: Merck Serano | Publiziert am 18.03.09 | Aktualisiert um 13:36 Uhr


Die Pressemitteilung Merck Serono and Fast Forward, LLC Announce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis wurde publiziert von Merck Serano am 18.03.2009 (Achtzehnter März). Die Meldung Merck Serono and Fast Forward, LLC Announce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis hat die ID News-HLP-25-497004.



Weitere Informationen und Links:

 Artikel 'Merck Serono and Fast Forward, LLC Announce ...' auf Swiss-Press.com




Braun Series 5 51-B1200s Rasierer

CHF -
Migros-Genossenschafts-Bund    Migros-Genossenschafts-Bund

Coca-Cola Classic

CHF 7.75 statt 14.10
Denner AG    Denner AG

Crosswave Fahrrad-Reiniger Reinigungsmittel

CHF 9.50 statt 11.90
Migros-Genossenschafts-Bund    Migros-Genossenschafts-Bund

Elfbar Elfa Pro Kit

CHF 7.90 statt 12.90
Denner AG    Denner AG

Halba Branches classic 50x23g

CHF 9.95 statt 22.00
Coop-Gruppe Genossenschaft    Coop-Gruppe Genossenschaft

Johnson’s Baby Shampoo

CHF 6.95 statt 10.50
Denner AG    Denner AG

Alle Aktionen »

Job's, Coaching, Karriere Coaching

Webdesign, Technologiepraxis, E-Commerce

Coiffeur, Hair-Stylist, Shooting, Shows

Produkt Design, Hosting Support, Agile Entwicklung, Strategie Scoping

Rénovation de baignoires et tubs de douche

IT-Dienstleister, Evernex IT Services Switzerland AG

Tierprodukte

Advokatur Büro, Rechtsanwalt

Verein, jüdische Gemeinde, jüdische Tradition

Alle Inserate »

8
11
25
26
27
35
1

Nächster Jackpot: CHF 7'500'000


2
13
14
26
29
5
6

Nächster Jackpot: CHF 50'000'000


Aktueller Jackpot:




Abonnieren Sie unseren News­letter



Newsletter